Diabetes Care 42(9):17241732 Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, Pratley R, Sathyapalan T, Desouza C (2019) Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Liraglutide From$113.99 CAS 204656-20-2 MW 3751.2 Liraglutide from the Nexus GLP-1 & Metabolic catalog, supplied for controlled in-vitro research workflows
Side effect profile: Both medications share a similar side effect profile dominated by GI symptoms like nausea, vomiting, and constipation
Put simply, this medication helps you feel full faster, curbs cravings, improves blood sugar control, and promotes fat breakdown